Contributors
Latest:
Tracking a Mystery in Non-Secretory MyelomaThere is no difference in treatment for non-secretory multiple myeloma and multiple myeloma, an expert told CURE®.
Latest:
Everybody Dies, With or Without CancerCancer may throw off a "plan" of where, when, why and how death happens.
Latest:
Jennifer Arnold on the Importance of ListeningJennifer Arnold, our MPN Heroes guest speaker, a physician and star of TLC’s reality TV show “The Little Couple,” discusses the importance of doctors and caregivers taking a moment to listen to patients and see how they are feeling.
Latest:
Delicate Difference: More Surgical Options for Prostate CancerInnovative approaches offer more surgical options with potentially fewer side effects.
Latest:
Personalized Precision Cancer Therapy Offers New Hope"My dream is for the day when all cancer patients can have testing to find out what treatment approach might work best for them—so that a patient with a specific genomic profile doesn’t miss an opportunity to get a potentially life-saving treatment when it’s out there."
Latest:
Suresh Ramalingam on Toxicities Associated With Immunotherapy in Different Disease TypesSuresh S. Ramalingam, a professor of medical oncology at the Winship Cancer Institute of Emory University, comments on the difference in toxicities associated with immunotherapy.
Latest:
11 Years After Losing My Hair to Chemo, I Decided to Donate My Locks to Children With CancerA breast cancer survivor explains why she was inspired to donate her hair to make wigs for children with cancer 11 years after she lost her own hair during chemotherapy treatments.
Latest:
PD-L1: An Important, But Imperfect BiomarkerSome immunotherapy drugs target the PD-L1 protein, though this expert says that it is still an imperfect biomarker.
Latest:
Novel HER-2 Targeted Agents Show Promise in Treating CNS MetastasesA recent study looking at data from three clinical trials involving Nerlynx shows promise for the future of treating patients with HER-2 positive breast cancer who develop CNS metastases.
Latest:
Brukinsa Viabie for Calquence-Intolerant B-Cell MalignanciesResults from an ongoing phase 2 study show the viability for the use of Brukinsa after patients with previously treated B-cell malignancies are deemed intolerant to the next-generation Bruton tyrosine kinase inhibitor Calquence.
Latest:
Gary Mervis on Putting Cancer on the "Front Burner"Gary Mervis, 2016 GBM Hero and founder of Camp Good Days and Special times, Inc., discusses the need for research in the field of glioblastoma multiforme (GBM).
Latest:
Sponsored Content: Grandmother With Advanced Bladder Cancer Finds Hope When Options Were LimitedBladder cancer is the sixth most common cancer in the U.S.
Latest:
Caregiver Challenge: Sharing Their PainCaregivers may grapple with practical and emotional challenges as they help loved ones manage cancer-related pain.
Latest:
Pairing Up Against Triple-Negative Breast CancerLinking a targeted drug to a chemotherapy shows promise for treating metastatic triple-negative breast cancer.
Latest:
Patient With Lung Cancer ‘Stays One Step Ahead’ of His Rare MutationA man with lung cancer shares how learning about his EGFR exon 20 insertion mutation soon after being diagnosed has allowed him to be aggressive when pursuing a cancer treatment tailored to his rare mutation.
Latest:
I’m Thankful for Early Cancer DetectionEven though I had no symptoms, my prostate cancer was caught thanks to frequent follow-ups with my doctor.
Latest:
Turning to CanadaWhen a Guatemalan family faced cancer, they turned to the country where they had dual citizenship — and to each other — for help.
Latest:
Growing Hope: Horticultural Therapy and Restorative GardensGardening helps cancer survivors truly thrive.
Latest:
Friendships and Cancer: A Delicate BalanceWhat is the appropriate reaction when a friend is diagnosed with cancer? Should you be sympathetic, optimistic, questioning? How do you handle your own fears—those you feel for your friend and, particularly as you grow older, those that evoke the possibility of personal loss and even the reality of your own vulnerability?
Latest:
More Than Friends Sends a Message of Health at Annual Tea PartyLorén Barbosa, co-chairperson of More Than Friends, discussed the Latino/Caribbean/American organization's Annual Tea Party and the their goal of sending a message of overall health and wellness.
Latest:
Lee Schwartzberg on Nausea Concerns for Newly Diagnosed PatientsLee Schwartzberg, executive director of the University of Tennessee West Cancer Center, discusses concerns that patients newly diagnosed with cancer have about chemotherapy-induced nausea and vomiting (CINV).
Latest:
CURE Community Vlog: Staying Healthy During the COVID-19 Pandemic“I’m not going to give up on that just because of this pandemic. Health is most important, as it should be for us cancer survivors.”
Latest:
After Diagnosis: Finding Your 'New Normal'“Sometimes ‘a new normal’ seems to have a bad connotation,” said Nicole Lise Feingold, director of Patient Services at the Pancreatic Cancer Action Network (PanCAN).
Latest:
A Tireless Patient AdvocateAn Extraordinary Healer essay honoring JESSICA BRANDT, B.S.N., RN, OCN [MELANOMA CLINIC, DEPARTMENT OF ONCOLOGY, MAYO CLINIC, ROCHESTER, MINNESOTA]
Latest:
NCCN May Already Be Updating MPN GuidelinesAfter publishing them in October 2016,the National Comprehensive Cancer Network (NCCN) is already seeking to update and expand their guidelines for diagnosing and treating patients with myeloproliferative neoplasms (MPNs).
